scispace - formally typeset
Journal ArticleDOI

The mechanisms underlying olfactory deficits in apolipoprotein E-deficient mice: focus on olfactory epithelium and olfactory bulb.

Reads0
Chats0
TLDR
This study demonstrates the critical involvement of ApoE in olfactory information processing in the OE and OB and shows that gamma oscillation power was enhanced, which might be attributed to an increase in GABAergic inhibition mediated by parvalbumin-expressing interneurons.
About
This article is published in Neurobiology of Aging.The article was published on 2018-02-01. It has received 22 citations till now. The article focuses on the topics: Olfaction & Olfactory bulb.

read more

Citations
More filters
Journal ArticleDOI

The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases

TL;DR: Connectomic approaches reveal a number of hubs in the olfactory system that are key interconnectors with the main hubs of network dysfunction in Alzheimer's and Parkinson's diseases, and why some neuronal populations are vulnerable while others are resistant to pathology and to what extent glia prevent and/or facilitate proteinopathy spreading.
Journal ArticleDOI

Functional Connectivity between the Resting-State Olfactory Network and the Hippocampus in Alzheimer's Disease.

TL;DR: Findings provide the first in vivo evidence for the involvement of FC between the ON and hippocampus in AD pathology, and suggest that functional connectivity between the olfactory network (ON) and hippocampus may be a sensitive marker for Alzheimer’s disease (AD) progression, preceding gray matter volume loss.
Journal ArticleDOI

Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models

TL;DR: In this article, the authors conducted in vivo measurement of local field potential (LFP) with a combination of electroolfactogram (EOG), whole-cell patch and field recordings to evaluate oscillatory and synaptic function and pharmacological regulation in the olfactory pathway.
Journal ArticleDOI

Alzheimer's Disease: What Can We Learn From the Peripheral Olfactory System?

TL;DR: Olfactory impairments could be used to understand the molecular mechanisms involved in the early phases of the pathology, highlighting how the olfactory epithelium and the OB are particularly sensitive to changes in proteins and enzymes involved in AD pathogenesis.
Journal ArticleDOI

Microglial activation in the dorsal striatum participates in anxiety-like behavior in Cyld knockout mice.

TL;DR: Results suggest that Cyld knockout leading to microglial activation promotes IL-1 β and TNF- α expression and acts as a critical pathway in the pathophysiology of anxiety.
References
More filters
Journal ArticleDOI

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

TL;DR: Apolipoprotein E is a plasma protein that serves as a ligand for low density lipoprotein receptors and, through its interaction with these receptors, participates in the transport of cholesterol and other lipids among various cells of the body.
Journal ArticleDOI

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

TL;DR: The A β-dependent and Aβ-independent mechanisms that link Apo-E4 status with AD risk are discussed, and how to design effective strategies for AD therapy by targeting ApO-E is considered.
Journal ArticleDOI

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

TL;DR: Optogenetics opens the door to a new kind of informational analysis of brain function, permitting quantitative delineation of the functional significance of individual elements in the emergent operation and function of intact neural circuitry.
Journal ArticleDOI

Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E

TL;DR: Apolipoprotein E-deficient mice generated by gene targeting were used to test this hypothesis and to make a mouse model for spontaneous atherosclerosis, with severe yet viable phenotype that should make them valuable for investigating genetic and environmental factors that modify the atherogenic process.
Journal ArticleDOI

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

TL;DR: Oral administration of the RXR agonist bexarotene to a mouse model of AD resulted in enhanced clearance of soluble Aβ within hours in an apoE-dependent manner, and stimulated the rapid reversal of cognitive, social, and olfactory deficits and improved neural circuit function.
Related Papers (5)